MethylPREDNISolone NDC 0603-4593

NDC codes

FDA NDC Directory

Product NDC (as listed)0603-4593Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00603-4593Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0603-4593-15	00603459315	1 DOSE PACK in 1 CARTON (0603-4593-15) / 21 TABLET in 1 DOSE PACKMarketed from Dec 22, 1998
0603-4593-21	00603459321	100 TABLET in 1 BOTTLE, PLASTIC (0603-4593-21)Marketed from Dec 22, 1998

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): MethylPREDNISolone
Generic name (nonproprietary): methylprednisolone
Active ingredients: Methylprednisolone — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Par Health USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040183
Marketing start: Dec 22, 1998
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0603-4593_61876830-b7d4-464d-b825-75e7a08627e3SPL ID 61876830-b7d4-464d-b825-75e7a08627e3SPL set ID c84cf5e6-746d-41fb-b3d8-2c0b8ba989afRxCUI 259966, 762675UNII X4W7ZR7023UPC 0306034593212
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400603459315 followed by a unit qualifier and the quantity

Package 00603-4593-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040183

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040183
Product	Strength	Form · route	Labeler	Product NDC
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	American Health Packaging	68084-149
MethylPREDNISolone	Methylprednisolone 4 mg/1	TabletOral	Bryant Ranch Prepack	63629-2218
MethylPREDNISolone	Methylprednisolone 4 mg/1	TabletOral	Bryant Ranch Prepack	63629-2226
MethylPREDNISolone	Methylprednisolone 4 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	55289-649
MethylPREDNISolone	Methylprednisolone 4 mg/1	TabletOral	Bryant Ranch Prepack	72162-1161